WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002003980) ANTI-INFLAMMATORY AND ANALGESIC AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/003980    International Application No.:    PCT/JP2001/005485
Publication Date: 17.01.2002 International Filing Date: 27.06.2001
Chapter 2 Demand Filed:    06.12.2001    
IPC:
A61K 31/05 (2006.01), A61K 31/085 (2006.01), A61K 31/136 (2006.01)
Applicants: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD. [JP/JP]; 1, Chudoji Awata-cho, Shimogyo-ku Kyoto-shi, Kyoto 600-8815 (JP) (For All Designated States Except US).
OGURA, Tetsuya [JP/MX]; (MX) (For US Only).
SANCHEZ, Maria Yolanda [MX/MX]; (MX) (For US Only).
KUBO, Isao [JP/US]; (US) (For US Only)
Inventors: OGURA, Tetsuya; (MX).
SANCHEZ, Maria Yolanda; (MX).
KUBO, Isao; (US)
Agent: SAEGUSA, Eiji; Kitahama TNK Building 1-7-1, Doshomachi, Chuo-ku Osaka-shi, Osaka 541-0045 (JP)
Priority Data:
2000-204488 06.07.2000 JP
Title (EN) ANTI-INFLAMMATORY AND ANALGESIC AGENTS
(FR) AGENTS ANTI-INFLAMMATOIRES ET ANALGESIQUES
Abstract: front page image
(EN)An anti-inflammatory or analgesic agent consisting of at least one member selected from the group consisting of compounds of the general formula (1) and pharmaceutically acceptable salts thereof; and pharmaceutical compositions containing the agent (1) wherein R?1¿ is hydrogen or the like; R?2¿ is hydroxyl or the like; R?3¿ is C¿1-6? alkyl; R?4¿, R?5¿ and R?6¿ are each hydrogen or the like; R?7¿ is C¿1-6? alkyl; and R?8¿s are each independently C¿1-6? alkyl.
(FR)L'invention concerne un agent anti-inflammatoire ou analgésique constitué d'au moins un élément sélectionné dans le groupe constitué par des composés de la formule (I) et des sels pharmaceutiquement acceptables desdits composés; et des compositions pharmaceutiques contenant ledit agent. Dans ladite formule (I) R?1¿ est hydrogène ou analogue; R?2¿ est hydroxyle ou analogue; R?3¿ est alkyle C¿1-6?; R?4¿, R?5¿ et R?6¿ sont chacun hydrogène ou analogue; R?7¿ est alkyle C¿1-6?; et les R?8¿ sont chacun indépendamment alkyle C¿1-6?.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)